• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

New Delhi, July 29

In a bid to counter the growing menace of fake drugs, the Drug Controller General of India is planning to conduct a nationwide survey covering as many as 31,000 combinations and 62 drugs. “We will conduct a national-level survey to know the extent of the problem of counterfeit drugs in the country which will begin from later part of the second half of the current year,” said the Drug Controller General of India, Mr Surinder Singh, in an interactive session with Brazilian business delegation organised by the Confederation of Indian Industries. The survey would be completed by the end of the year, he added. Earlier, the WHO had said that 10-125 per cent of drugs in India are counterfeit. —

Our Bureau

More Stories on : Pharmaceuticals | Piracy | Regulatory Bodies & Rulings

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Clinton Foundation seeks land for power plant in Anantapur

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line